Patient Pathfinder: Clinical Trials
Clinical Trials for Myeloproliferative Neoplasms
Every life-saving or life-extending treatment that's available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myeloproliferative Neoplasms (MPNs), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it's approved by the U.S. Food and Drug Administration.
There are 127 active Myeloproliferative Neoplasms trials
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs
P1101 in Treating Patients With Myelofibrosis
An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis on Concomitant JAK2 Inhibitor Therapy and Who Require Red Blood Cell Transfusions
Ruxolitinib in Thrombocythemia and Polycythemia Vera
Safety and Tolerability Study of Oral ABBV-744 Tablet Alone or in Combination With Oral Ruxolitinib Tablet or Oral Navitoclax Tablet in Adult Participants With Myelofibrosis
Project: Every Child for Younger Patients With Cancer
Study of DISC-0974 in Participants With Myelofibrosis and Anemia
There are 127 active Myeloproliferative Neoplasms trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.